PAH News

February 14, 2019February 20, 2019

Ventavis Improves Right Ventricle Function in Certain PAH Patients, Study Shows

News, PAH News

Acute treatment with Ventavis (iloprost) improves the heart’s right ventricular (RV) function in patients with idiopathic pulmonary arterial hypertension (IPAH) and PAH associated with connective tissue disease (CTD-PAH), according ... Read more

February 8, 2019February 14, 2019

Generic Version of Adcirca to be Launched in US Under Brand Name ALYQ for PAH

News, PAH News

Teva Pharmaceutical Industries announced the launch of a generic version of Adcirca (tadalafil) under the brand name ALYQ for the treatment of pulmonary arterial hypertension (PAH) in the United States. PAH ... Read more

February 4, 2019February 7, 2019

Early Results on Rodatristat Ethyl Support Launch of Phase 2 Trial in PAH Patients

News, PAH News

Preclinical and early clinical data showing the safety and potential therapeutic activity of rodatristat ethyl support its progression into Phase 2 trials in patients with pulmonary arterial hypertension (PAH). ... Read more

January 30, 2019January 31, 2019

United Therapeutics Gains Global Rights to Potential PAH Therapy Ralinepag

News, PAH News

United Therapeutics has now acquired worldwide rights over ralinepag, a potential oral medication under Phase 2 and 3 clinical testing for pulmonary arterial hypertension (PAH), the company announced in a press ... Read more

January 23, 2019February 4, 2019

PAH Prevalence in South Korea Comparable with Other Countries, Study Shows

News, PAH News

The prevalence of pulmonary arterial hypertension (PAH) in South Korea is comparable with that reported in other countries, according to a reassessment study of medical insurance data. The study, ... Read more

January 16, 2019January 23, 2019

Tracleer May Be More Cost-effective Than Some Other PAH Therapies, Review Study Reports

News, PAH News

Treatment of pulmonary arterial hypertension (PAH) with Tracleer (bosentan) may be more cost-effective than epoprostenol medications or palliative care, but less than Revatio (sildenafil) and other endothelin receptor blockers, ... Read more

January 14, 2019January 17, 2019

β-thalassemia Patients at Risk for PAH Show Improvements on Tracleer, Case Report Says

News, PAH News

Tracleer (bosentan) treatment improves mean pulmonary arterial pressure (mPAP) in β-thalassemia patients with potential pulmonary arterial hypertension (PAH), according to a case report of three patients. The report, “The ... Read more

January 11, 2019January 14, 2019

Long-term Adempas Treatment May Reverse Right Heart Deficits in Patients with PAH, CTEPH, Study Finds

CTEPH News, News, PAH News

Long-term treatment with Adempas (riociguat) can reduce right heart size and improve the heart’s pumping function in patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH), ... Read more

January 7, 2019January 7, 2019

Repeated Measurements of Biomarkers May Improve Prognostic Accuracy in PAH-CHD Patients, Study Finds

News, PAH News

Repeated measurements of different biomarkers over time offer a better risk prediction than single measurements for pulmonary arterial hypertension (PAH) associated with congenital heart disease, a study reports. The ... Read more

January 2, 2019January 15, 2019

PAH News

Ventavis Improves Right Ventricle Function in Certain PAH Patients, Study Shows

Generic Version of Adcirca to be Launched in US Under Brand Name ALYQ for PAH

Early Results on Rodatristat Ethyl Support Launch of Phase 2 Trial in PAH Patients

United Therapeutics Gains Global Rights to Potential PAH Therapy Ralinepag

PAH Prevalence in South Korea Comparable with Other Countries, Study Shows

Tracleer May Be More Cost-effective Than Some Other PAH Therapies, Review Study Reports

β-thalassemia Patients at Risk for PAH Show Improvements on Tracleer, Case Report Says

Long-term Adempas Treatment May Reverse Right Heart Deficits in Patients with PAH, CTEPH, Study Finds

Repeated Measurements of Biomarkers May Improve Prognostic Accuracy in PAH-CHD Patients, Study Finds

Top 10 Pulmonary Hypertension Stories of 2018

Pin It on Pinterest